Unbilled Professional Services bei mehrfachen Regulierungsanfragen
Definition
Implicit in search result [1]: The Medical Research Act acknowledges fragmented guidance ('inconsistencies in the interpretation especially of the ATMP laws and GMP/GCP guidelines') and proposes official federal interpretation recommendations. Currently, firms must hire external consultants to navigate state-level interpretation variance. Each state or federal inquiry triggers 30–50 hours of consulting work, much of it unbilled because it's classified as internal compliance overhead rather than project-specific consulting.
Key Findings
- Financial Impact: €60,000–€150,000 annually (2–4 regulatory consulting engagements per firm × €20,000–€50,000 per engagement, partially or fully unbilled). Estimated 200–300 unbilled professional hours/year at €50–€100/hour.
- Frequency: 3–6 regulatory inquiries per clinical trial (state-level + federal clarifications)
- Root Cause: No unified regulatory guidance; firms must hire consultants to translate state-specific terminology and requirements. Consulting hours not tracked against project budgets (compliance overhead).
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Biotechnology Research.
Affected Stakeholders
Regulatory Affairs Manager, Chief Compliance Officer, Finance/Project Manager, External Consultants
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.